tiprankstipranks
pc:exciv

Exciva

https://www.exciva.com/
Exciva is a clinical-stage biopharmaceutical company focused on developing novel therapies for behavioral symptoms associated with Alzheimer's disease (AD). The company is advancing Deraphan, a combination therapy comprising two clinically validated compounds including a new chemical entity, aiming to provide a differentiated safety and efficacy profile for agitation in AD patients.

Leadership & Board

Current Number of Employees7
Current LinkedIn Followers763

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$51M
Total Amount Raised$51M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$51M
Latest Funding Amount$51M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

Exciva had 7 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
7Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Exciva had 763 followers as of September 7, 2026. The number of followers increased by 2 (0.26%) week-over-week.
763Latest Followers Count
2(0.26%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 20, 2026
Series B
$51.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Exciva, helping you discover and navigate related company profiles.

Related News and Analysis